Menu Back to 07-Special-Populations

Track 7: Special Populations

DIA 2017: Driving Insights to Action! 

With 16 sessions specific to Special Populations, this track focuses on some of the greater challenges in therapeutic development for special populations, providing current thinking and sharing real-world experiences and outcomes that attendees can apply in their own programs. Special populations, when looked at together, make up a large component of the total population whose health concerns we seek to address. Each special population has unique characteristics and needs, which present challenges during the development of effective and accessible treatments. 

This year’s program is rich with topics of relevance to those developing or contemplating development of rare disease therapies. Additionally, therapeutic development issues for pediatric, prenatal, and lactating populations are addressed. Innovations in research and development with promise to accelerate the availability of treatments for the special therapeutics areas of CNS and neurodegenerative diseases and oncology will be highlighted.

Highlights in Special Populations

  • Introduction to rare disease studies
  • Patient voice in rare disease across the development continuum and the key to meaningful patient outcomes
  • MUST haves: engagement, education, networks, media, and societies in rare disease research
  • Collaborative efforts to accelerate rare disease research and development
  • Recruiting rare disease populations
  • Innovative design and statistics for small populations
  • Serving the patient in need of early access to treatment
  • Pregnancy and lactation – meeting the requirements for labeling 
  • Pediatric populations
  • CNS impairment guidelines and impact on therapies for brain diseases/disorders
  • State of neurodegenerative disease therapy research
  • Featured Topics in Rare Disease, Patient CentricityPediatrics, Academic Clinical Researcher, and Career Development

DIA recommends this track and associated sessions to professionals involved in: clinical research, early development (including Clinical Pharmacology), rare disease therapy development or approvals, regulatory affairs, medical affairs, patient affairs or advocacy, patient support services, statistics, pediatrics, and population and health outcomes research.

Sessions in Special Populations

Monday, June 19

Tuesday, June 20

Wednesday, June 21

Thursday, June 22


Registration Rates

Back to DIA 2017

Back to DIAglobal.org